Chances of Developing Gout Are Higher for Patients With IBD
September 28th 2023Study links inflammatory bowel disease diagnosis to increased gout risk, with Crohns disease and ulcerative colitis linked to 68% and 38% increases in likelihood of developing gout, respectively, relative to counterparts without IBD.
Can Cognitive Behavioral Therapy Change Quality of Life for AD Patients?
Cognitive behavioral therapy with exposure treatment might help but few people with AD receive any form of behavioral intervention, say Dorian Kern and colleagues from Karolinska Institutet, Stockholm.
ICER Updates its Assessment Framework to Include New Measures of Value
September 25th 2023ICER adds a more formal process to evaluate the diversity of clinical trials and an assessment of a product’s impact on patient and caregiver productivity. ICER also plans to evaluate how newer methods — which would consider the change of a drug’s price over time and disease severity — can be applied to its value assessment.
FDA Updates for the Week of Sept. 18, 2023
September 23rd 2023The FDA has approved GSK’s myelofibrosis drug, as well as a new indication for Jardiance and a new dosing regimen for Talicia. The agency has also issued a complete response letter for epinephrine nasal spray and assigned a review date for the gene therapy atidarsagene autotemcel.
HHS Grants $45 Million to Long COVID Clinics to Transform Healthcare for Underserved Populations
September 21st 2023There are nine grant awards of $1 million each for up to 5 years — totaling to overall $45 million in grants — that would mainly support underserved, rural, vulnerable, and minority populations that are disproportionately impacted by the effects of Long COVID
Enrollment in Early Phase Trial of HIV Vaccine That Uses a Cytomegalovirus Vector Is Underway
Early results are expected late next year from the phase 1 trial, which is being funded by the National Institute of Allergy and Infecious Diseases, the Bill & Melinda Gates Foundation and Vir Biotechnology, a San Franciso biotech company focused on vaccines and infectious disease.
Emerging Leaders in Healthcare: Lindsay Zimmerman of Upfront Healthcare
September 21st 2023Lindsay Zimmerman, Ph.D., M.P.H., vice president of Bartosch Patient Activation Institute at Upfront Healthcare, is one of the 12 up-and-coming leaders in healthcare included in the annual Managed Healthcare Executive feature.